1. Home
  2. CRSP vs SKY Comparison

CRSP vs SKY Comparison

Compare CRSP & SKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$60.11

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

SKY

Skyline Champion Corporation

HOLD

Current Price

$93.25

Market Cap

4.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
SKY
Founded
2013
2010
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.8B
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
CRSP
SKY
Price
$60.11
$93.25
Analyst Decision
Buy
Buy
Analyst Count
17
2
Target Price
$70.00
$101.00
AVG Volume (30 Days)
1.5M
835.1K
Earning Date
05-15-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.18
EPS
N/A
3.12
Revenue
$289,590,000.00
$2,483,448,000.00
Revenue This Year
$1,603.19
$7.75
Revenue Next Year
$78.75
$3.48
P/E Ratio
N/A
$29.76
Revenue Growth
9169.85
22.65
52 Week Low
$30.06
$59.44
52 Week High
$78.48
$103.93

Technical Indicators

Market Signals
Indicator
CRSP
SKY
Relative Strength Index (RSI) 61.24 54.79
Support Level $58.40 $73.46
Resistance Level $60.40 $95.38
Average True Range (ATR) 3.03 3.46
MACD 1.16 0.12
Stochastic Oscillator 86.78 64.24

Price Performance

Historical Comparison
CRSP
SKY

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.

Share on Social Networks: